These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27373369)

  • 21. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.
    Ontiveros-Torres MÁ; Labra-Barrios ML; Díaz-Cintra S; Aguilar-Vázquez AR; Moreno-Campuzano S; Flores-Rodríguez P; Luna-Herrera C; Mena R; Perry G; Florán-Garduño B; Luna-Muñoz J; Luna-Arias JP
    J Alzheimers Dis; 2016 Mar; 52(1):243-69. PubMed ID: 27031470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plaque-associated alpha-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein.
    Yang F; Uéda K; Chen P; Ashe KH; Cole GM
    Brain Res; 2000 Jan; 853(2):381-3. PubMed ID: 10640638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease.
    DeMattos RB; O'dell MA; Parsadanian M; Taylor JW; Harmony JA; Bales KR; Paul SM; Aronow BJ; Holtzman DM
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10843-8. PubMed ID: 12145324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ubiquilin-1 immunoreactivity is concentrated on Hirano bodies and dystrophic neurites in Alzheimer's disease brains.
    Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K
    Neuropathol Appl Neurobiol; 2013 Dec; 39(7):817-30. PubMed ID: 23421764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NDP52 associates with phosphorylated tau in brains of an Alzheimer disease mouse model.
    Kim S; Lee D; Song JC; Cho SJ; Yun SM; Koh YH; Song J; Johnson GV; Jo C
    Biochem Biophys Res Commun; 2014 Nov; 454(1):196-201. PubMed ID: 25450380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.
    Sheng JG; Mrak RE; Griffin WS
    Neuropathol Appl Neurobiol; 1995 Aug; 21(4):290-301. PubMed ID: 7494597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spreading of Alzheimer tau seeds is enhanced by aging and template matching with limited impact of amyloid-β.
    Nies SH; Takahashi H; Herber CS; Huttner A; Chase A; Strittmatter SM
    J Biol Chem; 2021 Oct; 297(4):101159. PubMed ID: 34480901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain Abeta amyloidosis in APPsw mice induces accumulation of presenilin-1 and tau.
    Tomidokoro Y; Harigaya Y; Matsubara E; Ikeda M; Kawarabayashi T; Shirao T; Ishiguro K; Okamoto K; Younkin SG; Shoji M
    J Pathol; 2001 Aug; 194(4):500-6. PubMed ID: 11523060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
    Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse.
    Zhao H; Chang R; Che H; Wang J; Yang L; Fang W; Xia Y; Li N; Ma Q; Wang X
    Neurosci Lett; 2013 Sep; 551():12-6. PubMed ID: 23810804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of incomplete mouse models of Alzheimer's disease.
    Radde R; Duma C; Goedert M; Jucker M
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35 Suppl 1():S70-4. PubMed ID: 18270700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plaque biogenesis in brain aging and Alzheimer's disease. II. Progressive transformation and developmental sequence of dystrophic neurites.
    Su JH; Cummings BJ; Cotman CW
    Acta Neuropathol; 1998 Nov; 96(5):463-71. PubMed ID: 9829809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutamate but not interleukin-6 influences the phosphorylation of tau in primary rat hippocampal neurons.
    Hüll M; Eistetter J; Fiebich BL; Bauer J
    Neurosci Lett; 1999 Feb; 261(1-2):33-6. PubMed ID: 10081920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
    Thal DR; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
    [No Abstract]   [Full Text] [Related]  

  • 39. Inositol trisphosphate 3-kinase B is increased in human Alzheimer brain and exacerbates mouse Alzheimer pathology.
    Stygelbout V; Leroy K; Pouillon V; Ando K; D'Amico E; Jia Y; Luo HR; Duyckaerts C; Erneux C; Schurmans S; Brion JP
    Brain; 2014 Feb; 137(Pt 2):537-52. PubMed ID: 24401760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.
    Ramos-Rodriguez JJ; Jimenez-Palomares M; Murillo-Carretero MI; Infante-Garcia C; Berrocoso E; Hernandez-Pacho F; Lechuga-Sancho AM; Cozar-Castellano I; Garcia-Alloza M
    Psychoneuroendocrinology; 2015 Dec; 62():69-79. PubMed ID: 26254770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.